Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genome-Wide Association Analysis for Triazole Resistance in Aspergillus fumigatus

4 Jun 2021

Abstract excerpt

Aspergillus fumigatus is a ubiquitous fungus and the main agent of aspergillosis, a common fungal infection in the immunocompromised population. Triazoles such as itraconazole and voriconazole are the common first-line drugs for treating aspergillosis. However, triazole resistance in A. fumigatus has been reported in an increasing number of countries. While most studies of triazole resistance have focused on...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antifungal resistance and susceptibility
Share to Fungal Infections and Studies
Share to Plant Disease Resistance and Genetics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34199862
DOI: 10.3390/pathogens10060701

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genome-Wide Association Analysis for Triazole Resistance in Aspergillus fumigatusPMID 34199862Read ↗

Triazole-resistant Aspergillus fumigatus in the Netherlands between 1994 and 2022: a genomic and phenotypic studySemantic proximity Read ↗

Prevalence of cyp51A variants in a US collection of Aspergillus fumigatus clinical isolates and comparative analysis of their contribution to triazole antifungal resistance.Semantic proximity Read ↗

Development and validation of next-generation sequencing-based clinical test for triazole resistance prediction in Aspergillus fumigatus.Semantic proximity Read ↗

Genomic perspective of triazole resistance in clinical and environmental Aspergillus fumigatus isolates without cyp51A mutationsSemantic proximity Read ↗

Triazole resistance surveillance in Aspergillus fumigatus.Semantic proximity Read ↗

Triazole phenotypes and genotypic characterization of clinical Aspergillus fumigatus isolates in China.Semantic proximity Read ↗

Epidemiological and Genomic Landscape of Azole Resistance Mechanisms in Aspergillus FungiSemantic proximity Read ↗

High prevalence of clinical and environmental triazole-resistant Aspergillus fumigatus in Iran: is it a challenging issue?Semantic proximity Read ↗

Azole Resistance and cyp51A Mutation of Aspergillus fumigatus in a Tertiary Referral Hospital in TaiwanSemantic proximity Read ↗

Moving beyond multi-triazole to multi-fungicide resistance: Broader selection of drug resistance in the human fungal pathogen Aspergillus fumigatusSemantic proximity Read ↗

Hmg1 mutations in Aspergillus fumigatus and their contribution to triazole susceptibility.Semantic proximity Read ↗

Prevalence and mechanism of triazole resistance in Aspergillus fumigatus in a referral chest hospital in Delhi, India and an update of the situation in AsiaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.